{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:08:35Z","timestamp":1778900915906,"version":"3.51.4"},"reference-count":50,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Transcatheter aortic valve replacement has transformed the paradigm of care for patients with severe aortic stenosis (AS). With transcatheter aortic valve replacement now commercially approved for AS patients of all surgical risk, clinical decision-making regarding the initial mode of valve replacement (e.g. surgical versus transcatheter) and prosthesis type has become even more complex. The updated American College of Cardiology\/American Heart Association and European Society of Cardiology\/European Association for Cardio-Thoracic Surgery guidelines on valvular heart disease offer a strong foundation from which to address the nuances of the treatment of AS; however, there remain several clinical scenarios for which evidence and thus definitive societal recommendations are lacking. As such, the heart team continues to play an invaluable role in the management of the AS patient by combining available scientific evidence, expertise across disciplines, and the patient\u2019s preferences to optimize individualized patient care and healthcare resource usage.<\/jats:p>","DOI":"10.15420\/usc.2022.04","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T17:06:22Z","timestamp":1658768782000},"source":"Crossref","is-referenced-by-count":3,"title":["The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis"],"prefix":"10.15420","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-4196","authenticated-orcid":false,"given":"Sahoor","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-7471","authenticated-orcid":false,"given":"Tsuyoshi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-5637","authenticated-orcid":false,"given":"Suzanne J","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA; Baim Institute for Clinical Research, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961\u201372. https:\/\/doi.org\/10.1056\/NEJMoa0804626; PMID:\u00a019228612.","DOI":"10.1056\/nejmoa0804626"},{"key":"ref1","unstructured":"Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1514616; PMID:\u00a027040324."},{"key":"ref2","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052; PMID:\u00a030883058."},{"key":"ref3","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1816885; PMID:\u00a030883053."},{"key":"ref4","unstructured":"Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1700456; PMID:\u00a028304219."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1103510; PMID:\u00a021639811.","DOI":"10.1056\/NEJMoa1103510"},{"key":"ref6","unstructured":"Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597\u2013607. https:\/\/doi.org\/10.1056\/NEJMoa1008232; PMID:\u00a020961243."},{"key":"ref7","unstructured":"Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol 2020;76:2492\u2013516. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.595; PMID:\u00a033213729."},{"key":"ref8","unstructured":"Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1400590; PMID:\u00a024678937."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 2021;143:e72\u2013227. https:\/\/doi.org\/10.1161\/CIR.0000000000000923; PMID:\u00a033332150.","DOI":"10.1161\/cir.0000000000000923"},{"key":"ref10","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2022;60:ezac209. https:\/\/doi.org\/10.1093\/ejcts\/ezac209; PMID:\u00a035352803."},{"key":"ref11","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395; PMID:\u00a034453165."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Thyregod HGH, Ihlemann N, J\u00f8rgensen TH, et al. Five-year clinical and echocardiographic outcomes from the Nordic aortic valve intervention (NOTION) randomized clinical trial in lower surgical risk patients. Circulation 2019;139:2714\u201323. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036606; PMID:\u00a030704298.","DOI":"10.1161\/circulationaha.118.036606"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021;42:2912\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab375; PMID:\u00a034179981.","DOI":"10.1093\/eurheartj\/ehab375"},{"key":"ref14","unstructured":"Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol 2019;73:537\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.078; PMID:\u00a030732706."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Percy ED, Harloff MT, Hirji S, et al. Nationally representative repeat transcatheter aortic valve replacement outcomes: report from the Centers for Medicare and Medicaid Services. JACC Cardiovasc Interv 2021;14:1717\u201326. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.011; PMID:\u00a034353602.","DOI":"10.1016\/j.jcin.2021.06.011"},{"key":"ref16","unstructured":"Bapat VN, Zaid S, Fukuhara S, et al. Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international registry. JACC Cardiovasc Interv 2021;14:1978\u201391. https:\/\/doi.org\/10.1016\/j.jcin.2021.07.015; PMID:\u00a034556271."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Puskas JD, Kilgo PD, Thourani VH, et al. The Society of Thoracic Surgeons 30-day predicted risk of mortality score also predicts long-term survival. Ann Thorac Surg 2012;93:26\u201333. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.07.086; PMID:\u00a022000786.","DOI":"10.1016\/j.athoracsur.2011.07.086"},{"key":"ref18","unstructured":"Kacila M, Granov N, Omerbasic E, Memisevic N. Additive and logistic EuroSCORE in assessment of operative mortality in cardiac surgery. Med Arh 2008;62:298\u20139 [in Bosnian]. PMID:\u00a019469275."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Edwards FH, Cohen DJ, O\u2019Brien SM, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 2016;1:46\u201352. https:\/\/doi.org\/10.1001\/jamacardio.2015.0326; PMID:\u00a027437653.","DOI":"10.1001\/jamacardio.2015.0326"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Schiller W, Barnewold L, Kazmaier T, et al. The German Aortic Valve Score II. Eur J Cardiothorac Surg 2017;52:881\u20137. https:\/\/doi.org\/10.1093\/ejcts\/ezx282; PMID:\u00a028950361.","DOI":"10.1093\/ejcts\/ezx282"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kotting J, Schiller W, Beckmann A, et al. German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 2013;43:971\u20137. https:\/\/doi.org\/10.1093\/ejcts\/ezt114; PMID:\u00a023477927.","DOI":"10.1093\/ejcts\/ezt114"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Capodanno D, Barbanti M, Tamburino C, et al. A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2014;113:1851\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.014; PMID:\u00a024837264.","DOI":"10.1016\/j.amjcard.2014.03.014"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Iung B, Laouenan C, Himbert D, et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart 2014;100:1016\u201323. https:\/\/doi.org\/10.1136\/heartjnl-2013-305314; PMID:\u00a024740804.","DOI":"10.1136\/heartjnl-2013-305314"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30:74\u201380. https:\/\/doi.org\/10.1093\/eurheartj\/ehn523; PMID:\u00a019033261.","DOI":"10.1093\/eurheartj\/ehn523"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Durand E, Borz B, Godin M, et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013;111:891\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2012.11.056; PMID:\u00a023337835.","DOI":"10.1016\/j.amjcard.2012.11.056"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Ben-Dor I, Gaglia MA Jr, Barbash IM, et al. Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med 2011;12:345\u20139. https:\/\/doi.org\/10.1016\/j.carrev.2011.04.005; PMID:\u00a021741324.","DOI":"10.1016\/j.carrev.2011.04.005"},{"key":"ref27","unstructured":"Shared Cardiology. Tools: decision aids. https:\/\/sharedcardiology.wordpress.com\/tools\/. 2022."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Korteland NM, Ahmed Y, Koolbergen DR, et al. Does the use of a decision aid improve decision making in prosthetic heart valve selection? A multicenter randomized trial. Circ Cardiovasc Qual Outcomes 2017;10:e003178. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.003178; PMID:\u00a028228452.","DOI":"10.1161\/circoutcomes.116.003178"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kipp R, Lehman J, Israel J, et al. Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease. Catheter Cardiovasc Interv 2013;82:212\u20138. https:\/\/doi.org\/10.1002\/ccd.24399; PMID:\u00a022517566.","DOI":"10.1002\/ccd.24399"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016\u201324. https:\/\/doi.org\/10.1016\/S1053-2498(01)00298-4; PMID:\u00a011557198.","DOI":"10.1016\/s1053-2498(01)00298-4"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017;4:CD001431. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5; PMID:\u00a028402085.","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Coylewright M, O\u2019Neill E, Sherman A, et al. The learning curve for shared decision-making in symptomatic aortic stenosis. JAMA Cardiol 2020;5:442\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2019.5719; PMID:\u00a031995126.","DOI":"10.1001\/jamacardio.2019.5719"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Rothberg MB. PCI for stable angina: a missed opportunity for shared decision-making. Cleve Clin J Med 2018;85:105\u201321. https:\/\/doi.org\/10.3949\/ccjm.85gr.17004; PMID:\u00a029425088.","DOI":"10.3949\/ccjm.85gr.17004"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Lindeboom JJ, Coylewright M, Etnel JRG, et al. Shared decision making in the heart team: current team attitudes and review. Structural Heart 2021;5:163\u20137. https:\/\/doi.org\/10.1080\/24748706.2020.1859660.","DOI":"10.1080\/24748706.2020.1859660"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Godolphin W. Shared decision-making. Healthc Q 2009;12:e186\u201390. https:\/\/doi.org\/10.12927\/hcq.2009.20947; PMID:\u00a019667767.","DOI":"10.12927\/hcq.2009.20947"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Lauck S, Borregaard B, Lewis K, De Souza I. Implementation of shared decision-making for aortic stenosis: development of a patient decision aid. Eur J Cardiovasc Nurs 2021;20:zvab060.027. https:\/\/doi.org\/10.1093\/eurjcn\/zvab060.027.","DOI":"10.1093\/eurjcn\/zvab060.027"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Antonides CFJ, Mack MJ, Kappetein AP. Approaches to the role of the heart team in therapeutic decision making for heart valve disease. Struct Heart 2017;1:249\u201355. https:\/\/doi.org\/10.1080\/24748706.2017.1380377.","DOI":"10.1080\/24748706.2017.1380377"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Coylewright M, Mack MJ, Holmes DR, O\u2019Gara PT. A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. J Am Coll Cardiol 2015;65:1472\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.033; PMID:\u00a025857913.","DOI":"10.1016\/j.jacc.2015.02.033"},{"key":"ref39","unstructured":"Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 2012;60:2683\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.018; PMID:23122802."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Baron SJ, Wang K, House JA, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation 2019;139:877\u201388. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035236; PMID:\u00a030586747.","DOI":"10.1161\/CIRCULATIONAHA.118.035236"},{"key":"ref41","unstructured":"Cohen DJ. Economic outcomes of TAVR vs. SAVR for low-risk patients: results from the PARTNER 3 trial. Presented at Transcatheter Cardiovascular Therapeutics 2021, Orlando, FL, 5 November, 2021."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Baron SJ, Ryan MP, Moore KA, et al. Contemporary costs associated with transcatheter versus surgical aortic valve replacement in Medicare beneficiaries. Circ Cardiovasc Interv 2022;15:e011295. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.121.011295; PMID:\u00a035193382.","DOI":"10.1161\/circinterventions.121.011295"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study. JACC Cardiovasc Interv 2019;12:459\u201369. https:\/\/doi.org\/10.1016\/j.jcin.2018.12.020; PMID:\u00a030846085.","DOI":"10.1016\/j.jcin.2018.12.020"},{"key":"ref44","unstructured":"Butala NM. Economics of minimalist TAVR: results from the 3M-TAVR economic study. Presented at Transcatheter Valvular Therapeutics 2021, Miami, FL, 22 July 2022."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Patterson T, McConkey HZR, Ahmed-Jushuf F, et al. Long-term outcomes following heart team revascularization recommendations in complex coronary artery disease. J Am Heart Assoc 2019;8:e011279. https:\/\/doi.org\/10.1161\/JAHA.118.011279; PMID:\u00a030943827.","DOI":"10.1161\/jaha.118.011279"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Jack G, Arora S, Strassle PD, et al. Differences in inpatient outcomes after surgical aortic valve replacement at transcatheter aortic valve replacement (TAVR) and non-TAVR centers. J Am Heart Assoc 2019;8:e013794. https:\/\/doi.org\/10.1161\/JAHA.119.013794; PMID:\u00a031718443.","DOI":"10.1161\/jaha.119.013794"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Marcus G, Qiu F, Manoragavan R, et al. Temporal trends and drivers of heart team utilization in transcatheter aortic valve replacement: a population-based study in Ontario, Canada. J Am Heart Assoc 2021;10:e020741. https:\/\/doi.org\/10.1161\/JAHA.120.020741; PMID:\u00a034155897.","DOI":"10.1161\/jaha.120.020741"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol 2012;19:e232\u20138. https:\/\/doi.org\/10.3747\/co.19.944; PMID:\u00a022876151.","DOI":"10.3747\/co.19.944"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Kesson EM, Allardice GM, George WD, et al. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13\u00a0722 women. BMJ 2012;344:e2718. https:\/\/doi.org\/10.1136\/bmj.e2718; PMID:\u00a022539013.","DOI":"10.1136\/bmj.e2718"}],"container-title":["US Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2022.04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T17:06:56Z","timestamp":1658768816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2022.04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":50,"URL":"https:\/\/doi.org\/10.15420\/usc.2022.04","relation":{},"ISSN":["1758-390X","1758-3896"],"issn-type":[{"value":"1758-390X","type":"electronic"},{"value":"1758-3896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"article-number":"e19"}}